WO2023247999 - PEPTIDIC PAIN MODULATORS AND METHODS FOR PRODUCING AND USING THE SAME
National phase entry is expected:
Publication Number
WO/2023/247999
Publication Date
28.12.2023
International Application No.
PCT/IB2022/055898
International Filing Date
24.06.2022
Title **
[English]
PEPTIDIC PAIN MODULATORS AND METHODS FOR PRODUCING AND USING THE SAME
[French]
MODULATEURS PEPTIDIQUES DE LA DOULEUR ET LEURS PROCÉDÉS DE PRODUCTION ET D'UTILISATION
Applicants **
MAINLINE BIOSCIENCES (SHANGHAI) CO., LTD.
Inventors
YAN, Liang Zeng
ZHANG, Junge
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2258 | |
| EPO | Filing, Examination, Granting | 19615 | |
| Japan | Filing, Examination, Granting | 2663 | |
| South Korea | Filing, Examination, Granting | 3079 | |
| USA | Filing, Examination, Granting | 6540 |
Total:
34,155
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
is not a thiol-containing amino acid. Also provided are methods for using peptides treating pain and for drug abuse intervention.[French]
n'est pas un acide aminé contenant un thiol. L'invention concerne également des procédés d'utilisation de peptides traitant la douleur et pour une intervention d'abus de médicament.